Gavin A. Whitlock

1.7k citations

40 papers · 1.2k indexed · h-index 21

Impact in

Organic Chemistry top 5%
- Asymmetric Synthesis and Catalysis
- Cyclopropane Reaction Mechanisms
- Synthetic Organic Chemistry Methods
- Catalytic C–H Functionalization Methods
- Synthesis and Biological Evaluation
- Synthesis and biological activity
Computational Theory and Mathematics top 5%
- Computational Drug Discovery Methods

Papers in

Organic Chemistry 19
- Cyclopropane Reaction Mechanisms 6
- Asymmetric Synthesis and Catalysis 4
- Synthesis and Biological Evaluation 4
- Synthetic Organic Chemistry Methods 4
Urology 4

Co-authors: Florian Wakenhut J. Stephen Clark Manuel Pérez David S. Millan Alexander Alex Erick M. Carreira Paul V. Fish Alan Stobie
Journals: Bioorganic & Medicinal Chemistry Letters (19 papers)Journal of Medicinal Chemistry (4 papers)Tetrahedron Letters (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Chemical Communications (1 paper)
Partner nations: United Kingdom United States Switzerland

In The Last Decade

Gavin A. Whitlock

39 papers receiving 1.2k citations

Peers

Countries citing papers authored by Gavin A. Whitlock

Since Specialization

Citations

This map shows the geographic impact of Gavin A. Whitlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin A. Whitlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin A. Whitlock more than expected).

Fields of papers citing papers by Gavin A. Whitlock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin A. Whitlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin A. Whitlock. The network helps show where Gavin A. Whitlock may publish in the future.

Co-authors

The 25 scholars most cited alongside Gavin A. Whitlock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gavin A. Whitlock Line = papers co-authored together Gavin A. Whitlock links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract 618: Preclinical assessment of APL-030, a selective and orally bioavailable inhibitor of the integrated stress response regulator GCN2 with activity against acute myeloid leukemia Cancer Research ·Mónica Román-Trufero, Gavin A. Whitlock, Matthew J. Fuchter, Jevgenijs Prostaks, S. Hulshoff, Sereina A. Herzog, Armin Zebisch, Richard P. Butt, Holger W. Auner, V. Korunoska-Stevkovska	2024	1
2	Small-molecule anti-inflammatory drug compositions for the treatment of asthma: a patent review (2013 – 2014) Expert Opinion on Therapeutic Patents ·Paul A. Glossop, Gavin A. Whitlock, Karl R. Gibson	2015	0
3	Identification of Type‐II Inhibitors Using Kinase Structures Chemical Biology & Drug Design ·Frank Lovering, Joseph J. McDonald, Gavin A. Whitlock, Paul A. Glossop, Chris Phillips, Andrew F. Bent, Yogesh Sabnis, Mark Ryan, Lori Fitz, Julie Lee, Jeanne S. Chang, Seungil Han, Ravi G. Kurumbail, Atli Thorarensen	2012	17
4	Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: Improving metabolic stability and reducing ion channel activity Bioorganic & Medicinal Chemistry Letters ·M. Jonathan Fray, Paul V. Fish, Sherman Alexander Wengerd, Gerwyn Bish, Никифоров Игорь Яковлевич, م.م. الهام علی حسون, Anthony Harrison, Jean-Loïc Le Net, Stephen C. Phillips, Putri Ervina Hartini, Beatriz Columina, Alan Stobie, Florian Wakenhut, Syed Shazhad Hasan, Hospitial, Gavin A. Whitlock	2010	3
5	N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: Impact of small structural modifications on P-gp recognition and CNS penetration Bioorganic & Medicinal Chemistry Letters ·Florian Wakenhut, M. T. Magama, Paul V. Fish, M. Jonathan Fray, Anthony Harrison, Lapo Gianni, Stephen C. Phillips, Alan Stobie, Syed Shazhad Hasan, Hospitial, Gavin A. Whitlock	2009	7
6	Pharmacological Properties of 2-((R-5-Chloro-4-methoxymethylindan-1-yl)-1H-imidazole (PF-3774076), a Novel and Selective α1A-Adrenergic Partial Agonist, in in Vitro and in Vivo Models of Urethral Function Journal of Pharmacology and Experimental Therapeutics ·Kelly Conlon, Isabelle Thomas, Hospitial, Gavin A. Whitlock, Lee R. Roberts, Alan Stobie, Gordon McMurray	2009	10
7	6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective α1A adrenoceptor partial agonists Bioorganic & Medicinal Chemistry Letters ·Lee R. Roberts, Paul V. Fish, Richard Storer, Gavin A. Whitlock	2009	13
8	4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: Design, synthesis and structure–activity relationships Bioorganic & Medicinal Chemistry Letters ·Paul V. Fish, Mark D. Andrews, M. Jonathan Fray, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	2009	13
9	Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence Bioorganic & Medicinal Chemistry Letters ·Paul E. Brennan, Gavin A. Whitlock, Feronika Tabunria Simanjuntak, Kelly Conlon, Gordon McMurray	2009	8
10	Potent and selective α1A adrenoceptor partial agonists—Novel imidazole frameworks Bioorganic & Medicinal Chemistry Letters ·Gavin A. Whitlock, Paul E. Brennan, Lee R. Roberts, Alan Stobie	2009	10
11	Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity Bioorganic & Medicinal Chemistry Letters ·Gavin A. Whitlock, Paul V. Fish, M. Jonathan Fray, Alan Stobie, Florian Wakenhut	2008	22
12	Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition Bioorganic & Medicinal Chemistry Letters ·Paul V. Fish, Giorgos Vathiotis, X. Chen, Douglas Edwin Nordstrum, Zanna Andersson, Zhao Jia-bo, Kimberly S. Para, Kensei Tanaka, Thomas Ryckmans, Cory M. Stiff, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	2008	26
13	Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity Bioorganic & Medicinal Chemistry Letters ·Paul V. Fish, Nancy S. Barta, David Gray, Thomas Ryckmans, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	2008	11
14	Chloroquine–astemizole hybrids with potent in vitro and in vivo antiplasmodial activity Bioorganic & Medicinal Chemistry Letters ·Chitalu C. Musonda, Gavin A. Whitlock, Michael J. Witty, Reto Brun, Marcel Kaiser	2008	37
15	N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors Bioorganic & Medicinal Chemistry Letters ·Florian Wakenhut, Paul V. Fish, M. Jonathan Fray, Ian Gurrell, James E. Mills, Alan Stobie, Gavin A. Whitlock	2008	10
16	Novel 2-imidazoles as potent and selective α1A adrenoceptor partial agonists Bioorganic & Medicinal Chemistry Letters ·Gavin A. Whitlock, Kelly Conlon, Gordon McMurray, Lee R. Roberts, Alan Stobie, Richard J. Thurlow	2008	14
17	N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors Bioorganic & Medicinal Chemistry Letters ·Paul V. Fish, M. Jonathan Fray, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	2007	13
18	Structure–activity relationships of N-substituted piperazine amine reuptake inhibitors Bioorganic & Medicinal Chemistry Letters ·M. Jonathan Fray, Gerwyn Bish, Paul V. Fish, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	2006	18
19	N-(1,2-Diphenylethyl)piperazines: A new class of dual serotonin/noradrenaline reuptake inhibitor Bioorganic & Medicinal Chemistry Letters ·M. Jonathan Fray, Gerwyn Bish, Alan D. Brown, Paul V. Fish, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	2006	21
20	Stereoselective synthesis of tetrahydropyran-3-ones by rearrangement of oxonium ylides generated from metal carbenoids Chemical Communications ·J. Stephen Clark, Gavin A. Whitlock, Shende Jiang, Meity Mulya Susanti	2003	28

About Gavin A. Whitlock

Gavin A. Whitlock is a scholar working on Organic Chemistry, Urology, Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology, having authored 40 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cyclopropane Reaction Mechanisms (6 papers), Receptor Mechanisms and Signaling (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers), Asymmetric Synthesis and Catalysis (4 papers), Synthesis and Biological Evaluation (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Synthetic Organic Chemistry Methods (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Organic Chemistry (622 citations), Computational Theory and Mathematics (159 citations), Pharmacology (68 citations), Molecular Biology (452 citations) and Drug Discovery (1 citation). Gavin A. Whitlock has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Florian Wakenhut, J. Stephen Clark, Manuel Pérez, David S. Millan, Alexander Alex, Erick M. Carreira, Paul V. Fish, Alan Stobie, M. Jonathan Fray and Timothy P. Layzell. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Tetrahedron Letters, Journal of Pharmacology and Experimental Therapeutics and Chemical Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact